The Department of Health defended Sinovac Biotech Ltd.’s coronavirus vaccine amid mounting criticism on the government’s continued keenness to buy the shot despite it only being 50% effective according to late-stage trials in Brazil.
Full Post on Source: DOH defends Sinovac vaccine’s efficacy rate
